Transcriptional regulation of serum amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/enhancer binding proteins (C/EBP) and is distinct from HepG2 cells

Scandinavian Journal of Immunology

Volumn 56, Issue 5, 2002, Pages 504-511

  Kumon, Y ^a   Suehiro, T ^a   Faulkes, D J ^a   Hosakawa, T ^a   Ikeda, Y ^a   Woo, P ^a   Sipe, J D ^a   Hashimoto, K ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYTOKINE; ENHANCER BINDING PROTEIN; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PLASMID VECTOR; SERUM AMYLOID A; STEROID HORMONE; UNCLASSIFIED DRUG;

AORTA; ARTICLE; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DRUG RESPONSE; ENHANCER REGION; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION;

BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CYTOKINES; DEXAMETHASONE; DNA; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; SERUM AMYLOID A PROTEIN; STEROIDS; TRANSCRIPTION FACTOR AP-1;

EID: 0036435584     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01169.x     Document Type: Article

References (26)

1. Uhler CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999;265:501-23.
2. McAdam KPWJ, Elin R J, Sipe JD, Wolff SM. Changes in human serum amyloid A and C-reactive protein following etiocholanolone-induced inflammation. J Clin Invest 1978;66:390-4.
3. Whitehead AS, de Beer MC, Steel DM et al. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992;267:3862-7.
4. Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neuroscience 1997;225:73-6.
5. Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y. Widespread expression of serum amyloid A in histologically normal human tissues: Predominant localization to epithelium. J Histochem Cytochem 1998;46:1377-84.
6. Kumon Y, Suehiro T, Hashimoto K, Nakatani K, Sipe JD. Local expression of acute-phase serum amyloid A (A-SAA) mRNA in rheumatoid arthritis synovial tissue and cells. J Rheumatol 1999;26:758-90.
7. Meek RL, Ericksen N, Benditt EP. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci USA 1992;89:7949-52.
8. Kumon Y, Nakauchi Y, Suehiro T, Hashimoto K, Sipe JD. Serum amyloid A (SAA) gene expression by human aortic smooth muscle cells. In: Kyle RA, Gertz MA, eds. Amyloid and Amyloidosis. Pearl River, New York: Parthenon Publishing Group, 1998, 429-31.
9. Kumon Y, Suehiro T, Hashimoto K, Sipe JD. Dexamethasone, but not interleukin-1 alone, upregulates acute-phase serum amyloid A (A-SAA) expression and production by cultured human aortic smooth muscle cells. Scand J Immunol 2001;53:7-12.
10. Betts JC, Edbrooke MR, Thakker RV, Woo P. The human acute-phase serum amyloid A gene family: Structure, evolution and expression in hepatoma cells. Scand J Immunol 1991;34:471-82.
11. Smith JW, McDonald TL. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: The effects of prednisolone. Clin Exp Immunol 1992;90:293-9.
12. Gabay C, Genin B, Mentha G, Iynedjian PB, Roux-Lombard P. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells. Clin Exp Immunol 1995;100:306-13.
13. Li X, Liao WS. Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells. Nucleic Acids Res 1992;25:4765-72.
14. Ray A, Schatten H, Ray BK. Activation of Spl and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J Biol Chem 1999;274:4300-8.
15. Edbrooke MR, Burt DW, Cheshire JK, Woo P. Identification of cis-acting sequence responsible for phorbol ester induction of human serum amyloid A gene expression via nuclear factor kappaB-like transcription factor. Mol Cell Biol 1989;9:1908-16.
16. Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P. The role of NF-kappaB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem 1993;268:15624-31.
17. Uhlar CM, Grehan S, Steel DM, Steinkasserer A, Whitehead AS. Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: Differential kinetics of SAA2 promoter induction by IL-lb and TNF-0t compared to IL-6. J Immunol Methods 1997;203:123-30.
18. Yoshida K, Suehiro T, Yasuoka N, Kumon Y, Ohno F. Serum amyloid A protein in high density lipoprotein of acute myocardial infarction and in human atherosclerotic lesion. J Jpn Atherosclerosis Soc 1988;16:505-15.
19. Liang JS, Sipe JD. Recombinant human serum amyloid A (apoSAA) binds cholesterol and modulates cholesterol flux. J Lipid Res 1995;36:37-46.
20. Liang JS, Schreiber BM, Salmona M et al. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res 1996;37:2109-16.
21. Schreiber BM, Veverbrants M, Fine RE et al. Apolipoprotein serum amyloid A down-regulates smooth muscle cell lipid biosynthesis. Biochem J 1999;344:7-13.
22. Mitchell TI, Jeffrey JJ, Palmiter RD, Brinckerhoff CE. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim Biophys Acta 1993;1156:245-54.
23. Badolato R, Wang JM, Murphy WJ et al. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994;180:203-9.
24. Xu L, Badolato R, Murphy WJ et al. A novel biologic function of serum amyloid A: Induction of T lymphocyte migration and adhesion. J Immunol 1995;155:1184-90.
25. Wolfe F, Mitchell DM, Sibley JT et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
26. Raynauld JP. Cardiovascular mortality in rheumatoid arthritis: How harmful are corticosteroids? J Rheumatol 1997;24:415-7.